GL
GEN1E LIFESCIENCES INC.
SEC filingBiotechnology · Palo Alto, CA
Amount raised$5.5Msold at filing
Total offering$11.9M$6.4M still open
Investors in the raise44count reported to the SEC
FiledDec 29, 2025first sale Oct 21, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ritu LalExecutive Officer, Director
Francois NaderDirector
Alan LevyDirector
Noor KamruddinDirector
Soujanya BhumkarExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.